OPTIMIZING THE DOSE OF PLERIXAFOR IN LOW BODY WEIGHT PATIENTS WITH NON-HODGKIN'S LYMPHOMA.

被引：0
|
作者：
Ma, L. [1 ]
Habtemariam, B. [1 ]
Dinndorf, P. [1 ]
Mercado, M. S. [2 ]
Lin, T. [2 ]
Wang, Y. [1 ]
机构：
[1] US FDA, Silver Spring, MD USA
[2] Sanofi, Cambridge, MA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2016年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI-074
引用
收藏
页码：S50 / S51
页数：2
相关论文
共 50 条
  • [1] Plerixafor In Patients with Non-Hodgkin's Lymphoma or Multiple Myeloma
    Wagstaff, Antona J.
    DRUGS, 2009, 69 (03) : 319 - 326
  • [2] High-dose sequential chemotherapy in refractory Hodgkin's and non-Hodgkin's lymphoma.
    Oyan, B
    Koc, Y
    Kansu, E
    BLOOD, 2002, 100 (11) : 471B - 471B
  • [3] Treatment of elderly patients with aggressive non-Hodgkin's lymphoma.
    Paccalin, M
    Lacotte-Thierry, L
    Delwail, V
    REVUE DE MEDECINE INTERNE, 2002, 23 (07): : 632 - 637
  • [4] The leukemic phase of non-Hodgkin's lymphoma.
    Kim, JY
    Park, CJ
    Chi, HS
    Choi, SJ
    Huh, JR
    Kang, YK
    Suh, CW
    Kim, SB
    BLOOD, 2001, 98 (11) : 230B - 230B
  • [5] Pharmacokinetic profiles of fixed dose single pegfilgrastim administration in patients with non-Hodgkin's lymphoma.
    George, S
    Yunus, F
    Yang, BB
    Hackett, J
    Neumann, T
    Liang, B
    BLOOD, 2001, 98 (11) : 27B - 27B
  • [6] The prognostic value of body mass index in Hodgkin lymphoma and diffuse non-Hodgkin lymphoma.
    Turgut, Mehmet
    Kelkitli, Engin
    Atay, Memis Hilmi
    Cilingir, Fatih Mehmet
    Yilmaz, Bahiddin
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [7] Dose intensity as a treatment related variable in aggressive non-Hodgkin's lymphoma.
    Rodriguez, J
    Romaguera, J
    McLaughlin, P
    Hagemeister, F
    Rodriguez, M
    Cabanillas, F
    BLOOD, 1997, 90 (10) : 3947 - 3947
  • [8] Prognostic value of cytogenetic abnormalities in patients with non-Hodgkin's lymphoma.
    Juneja, S
    Matthews, J
    Lukeis, R
    Laidlaw, C
    Cooper, I
    Wolf, M
    Ironside, P
    Garson, OM
    BLOOD, 1995, 86 (10) : 2115 - 2115
  • [9] Rituximab in the treatment of patients with relapsed low-grade or follicular non-Hodgkin's lymphoma.
    Capote, FJ
    Bernabé, R
    Martin, MV
    Porta, J
    Almagro, M
    Moreno-Nogueira, JA
    Gil, JL
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S90 - S90
  • [10] Radiotherapy for non-Hodgkin's lymphoma. Important again?
    Schmidberger, H.
    Hey-Koch, S.
    ONKOLOGE, 2015, 21 (10): : 913 - 924
12345